Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
31/01/2022 | 13:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App | NASDAQ:OSUR | OraSure Technologies Inc |
28/01/2022 | 19:58 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OSUR | OraSure Technologies Inc |
25/01/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe | NASDAQ:OSUR | OraSure Technologies Inc |
13/01/2022 | 22:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants | NASDAQ:OSUR | OraSure Technologies Inc |
10/01/2022 | 22:35 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OSUR | OraSure Technologies Inc |
07/01/2022 | 22:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OSUR | OraSure Technologies Inc |
05/01/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Announces Actions to Enhance Stockholder Value | NASDAQ:OSUR | OraSure Technologies Inc |
14/12/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Announces 2022 Annual Meeting Date | NASDAQ:OSUR | OraSure Technologies Inc |
30/11/2021 | 22:08 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:OSUR | OraSure Technologies Inc |
30/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus | NASDAQ:OSUR | OraSure Technologies Inc |
19/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies to Present at Upcoming Investor Conferences | NASDAQ:OSUR | OraSure Technologies Inc |
09/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary | NASDAQ:OSUR | OraSure Technologies Inc |
08/11/2021 | 14:06 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OSUR | OraSure Technologies Inc |
08/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Appoints Two New Members to the Board of Directors | NASDAQ:OSUR | OraSure Technologies Inc |
03/11/2021 | 21:05 | GlobeNewswire Inc. | OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22 | NASDAQ:OSUR | OraSure Technologies Inc |
02/11/2021 | 14:36 | Dow Jones News | OraSure Up 7% After FDA Authorizes Covid-19 Rapid Tests for OTC Single-Use, At-Home Testing | NASDAQ:OSUR | OraSure Technologies Inc |
02/11/2021 | 12:05 | GlobeNewswire Inc. | U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection | NASDAQ:OSUR | OraSure Technologies Inc |
27/10/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
04/10/2021 | 13:05 | GlobeNewswire Inc. | OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of InteliSwab™ COVID-19 Rapid Test | NASDAQ:OSUR | OraSure Technologies Inc |
23/09/2021 | 14:10 | GlobeNewswire Inc. | OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver | NASDAQ:OSUR | OraSure Technologies Inc |
20/09/2021 | 13:44 | TipRanks | OraSure Procures $205M Contract from Defense Logistics Agency | NASDAQ:OSUR | OraSure Technologies Inc |
20/09/2021 | 12:00 | GlobeNewswire Inc. | OraSure Receives $205 Million Procurement Contract for InteliSwab™ from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response | NASDAQ:OSUR | OraSure Technologies Inc |
02/09/2021 | 13:00 | GlobeNewswire Inc. | OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan | NASDAQ:OSUR | OraSure Technologies Inc |
05/08/2021 | 22:28 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OSUR | OraSure Technologies Inc |
03/08/2021 | 22:05 | GlobeNewswire Inc. | OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business | NASDAQ:OSUR | OraSure Technologies Inc |
29/07/2021 | 15:20 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OSUR | OraSure Technologies Inc |
27/07/2021 | 22:01 | GlobeNewswire Inc. | OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
17/06/2021 | 22:05 | GlobeNewswire Inc. | OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference | NASDAQ:OSUR | OraSure Technologies Inc |
14/06/2021 | 12:00 | GlobeNewswire Inc. | OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing | NASDAQ:OSUR | OraSure Technologies Inc |
07/06/2021 | 15:18 | GlobeNewswire Inc. | OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (O... | NASDAQ:OSUR | OraSure Technologies Inc |